Cargando…
Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
SIMPLE SUMMARY: Doxorubicin (Dox) is a chemotherapeutic agent usually employed for the treatment of breast cancer. However, its use is limited because of the toxicities associated, and hence a proper delivery vehicle is necessary. In this sense, albumin-based nanocarriers are in the limelight for th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235501/ https://www.ncbi.nlm.nih.gov/pubmed/34208533 http://dx.doi.org/10.3390/cancers13123011 |